Effect of short‐term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes

AIM: Impaired awareness of hypoglycaemia (IAH) affects about 25% of patients with type 1 diabetes (T1DM). IAH can be reversed by strict avoidance of hypoglycaemia for at least 3 weeks. Adjunctive treatment with sodium glucose cotransporter 2 inhibitors may reduce the risk of hypoglycaemia through re...

Descripción completa

Detalles Bibliográficos
Autores principales: van Meijel, Lian A., Tack, Cees J., de Galan, Bastiaan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292159/
https://www.ncbi.nlm.nih.gov/pubmed/34338413
http://dx.doi.org/10.1111/dom.14505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292159/
https://www.ncbi.nlm.nih.gov/pubmed/34338413
http://dx.doi.org/10.1111/dom.14505

Ejemplares similares